These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30883650)

  • 1. Argininosuccinate synthase 1 suppresses cancer cell invasion by inhibiting STAT3 pathway in hepatocellular carcinoma.
    Tao X; Zuo Q; Ruan H; Wang H; Jin H; Cheng Z; Lv Y; Qin W; Wang C
    Acta Biochim Biophys Sin (Shanghai); 2019 Mar; 51(3):263-276. PubMed ID: 30883650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Argininosuccinate synthase 1 suppresses tumor progression through activation of PERK/eIF2α/ATF4/CHOP axis in hepatocellular carcinoma.
    Kim S; Lee M; Song Y; Lee SY; Choi I; Park IS; Kim J; Kim JS; Kim KM; Seo HR
    J Exp Clin Cancer Res; 2021 Apr; 40(1):127. PubMed ID: 33838671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of argininosuccinate synthetase is associated with cisplatin resistance in hepatocellular carcinoma cell lines: implications for PEGylated arginine deiminase combination therapy.
    McAlpine JA; Lu HT; Wu KC; Knowles SK; Thomson JA
    BMC Cancer; 2014 Aug; 14():621. PubMed ID: 25164070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway.
    Yang X; Liang L; Zhang XF; Jia HL; Qin Y; Zhu XC; Gao XM; Qiao P; Zheng Y; Sheng YY; Wei JW; Zhou HJ; Ren N; Ye QH; Dong QZ; Qin LX
    Hepatology; 2013 Jul; 58(1):158-70. PubMed ID: 23389848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
    Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W
    Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STAT3 cooperates with Twist to mediate epithelial-mesenchymal transition in human hepatocellular carcinoma cells.
    Zhang C; Guo F; Xu G; Ma J; Shao F
    Oncol Rep; 2015 Apr; 33(4):1872-82. PubMed ID: 25653024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STAT3 regulates the migration and invasion of a stem‑like subpopulation through microRNA‑21 and multiple targets in hepatocellular carcinoma.
    Zhang N; Duan WD; Leng JJ; Zhou L; Wang X; Xu YZ; Wang XD; Zhang AQ; Dong JH
    Oncol Rep; 2015 Mar; 33(3):1493-8. PubMed ID: 25571964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fucoidan-induced ID-1 suppression inhibits the in vitro and in vivo invasion of hepatocellular carcinoma cells.
    Cho Y; Cho EJ; Lee JH; Yu SJ; Kim YJ; Kim CY; Yoon JH
    Biomed Pharmacother; 2016 Oct; 83():607-616. PubMed ID: 27459117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Argininosuccinate synthetase 1 suppression and arginine restriction inhibit cell migration in gastric cancer cell lines.
    Shan YS; Hsu HP; Lai MD; Yen MC; Chen WC; Fang JH; Weng TY; Chen YL
    Sci Rep; 2015 Apr; 5():9783. PubMed ID: 25928182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation-mediated repression of microRNA-129-2 suppresses cell aggressiveness by inhibiting high mobility group box 1 in human hepatocellular carcinoma.
    Liu Z; Dou C; Yao B; Xu M; Ding L; Wang Y; Jia Y; Li Q; Zhang H; Tu K; Song T; Liu Q
    Oncotarget; 2016 Jun; 7(24):36909-36923. PubMed ID: 27191994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA LINC01234 promotes hepatocellular carcinoma progression through orchestrating aspartate metabolic reprogramming.
    Chen M; Zhang C; Liu W; Du X; Liu X; Xing B
    Mol Ther; 2022 Jun; 30(6):2354-2369. PubMed ID: 35192933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ID1 promotes hepatocellular carcinoma proliferation and confers chemoresistance to oxaliplatin by activating pentose phosphate pathway.
    Yin X; Tang B; Li JH; Wang Y; Zhang L; Xie XY; Zhang BH; Qiu SJ; Wu WZ; Ren ZG
    J Exp Clin Cancer Res; 2017 Nov; 36(1):166. PubMed ID: 29169374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of the Immunologic Co-Stimulator B7 and TNFR Families Correlate with Hepatocellular Carcinoma Prognosis and Metastasis by Inactivating STAT3.
    Li YM; Liu ZY; Li ZC; Wang JC; Yu JM; Yang HJ; Chen ZN; Tang J
    Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30609841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-137 suppresses migration and invasion by targeting EZH2-STAT3 signaling in human hepatocellular carcinoma.
    Huang B; Huang M; Li Q
    Pathol Res Pract; 2018 Dec; 214(12):1980-1986. PubMed ID: 30274685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydropyrimidine dehydrogenase predicts survival and response to interferon-α in hepatocellular carcinoma.
    Zhu WP; Liu ZY; Zhao YM; He XG; Pan Q; Zhang N; Zhou JM; Wang LR; Wang M; Zhan DH; Ma DN; Wang L
    Cell Death Dis; 2018 Jan; 9(2):69. PubMed ID: 29358721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA FEZF1-AS1 promotes cell invasion and epithelial-mesenchymal transition through JAK2/STAT3 signaling pathway in human hepatocellular carcinoma.
    Wang YD; Sun XJ; Yin JJ; Yin M; Wang W; Nie ZQ; Xu J
    Biomed Pharmacother; 2018 Oct; 106():134-141. PubMed ID: 29957463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sorafenib down-regulates expression of HTATIP2 to promote invasiveness and metastasis of orthotopic hepatocellular carcinoma tumors in mice.
    Zhang W; Sun HC; Wang WQ; Zhang QB; Zhuang PY; Xiong YQ; Zhu XD; Xu HX; Kong LQ; Wu WZ; Wang L; Song TQ; Li Q; Tang ZY
    Gastroenterology; 2012 Dec; 143(6):1641-1649.e5. PubMed ID: 22922424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRMT1 Promoted HCC Growth and Metastasis In Vitro and In Vivo via Activating the STAT3 Signalling Pathway.
    Zhang XP; Jiang YB; Zhong CQ; Ma N; Zhang EB; Zhang F; Li JJ; Deng YZ; Wang K; Xie D; Cheng SQ
    Cell Physiol Biochem; 2018; 47(4):1643-1654. PubMed ID: 29945155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YMO1 suppresses invasion and metastasis by inhibiting RhoC signaling and predicts favorable prognosis in hepatocellular carcinoma.
    Chang RM; Pei L; Fang F; Xu JF; Yang H; Zuo CH; Zhou JH; Luo GQ; Yang LY
    Oncotarget; 2016 Aug; 7(34):55585-55600. PubMed ID: 27487132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Argininosuccinate synthetase 1 contributes to gastric cancer invasion and progression by modulating autophagy.
    Tsai CY; Chi HC; Chi LM; Yang HY; Tsai MM; Lee KF; Huang HW; Chou LF; Cheng AJ; Yang CW; Wang CS; Lin KH
    FASEB J; 2018 May; 32(5):2601-2614. PubMed ID: 29401583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.